Ray Dalio acquired 26.4 Thousand Sarepta Therapeutics shares worth $3.11 Million. That's 0.02% of their equity portfolio (429th largest holding). The first Sarepta Therapeutics trade was made in Q1 2021. Since then Ray Dalio bought shares four more times and sold shares on six occasions. The stake costed the investor $2.09 Million, netting the investor a gain of 49% so far.